DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9%
Thu, 6 Feb

DIVIS LABORATORIES has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

DIVIS LABORATORIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m13,42914,45613,905-3.8%3.5%
Other incomeRs m346470403-14.3%16.6%
TurnoverRs m13,77514,92614,308-4.1%3.9%
ExpensesRs m8,1969,5508,936-6.4%9.0%
Gross profitRs m5,2334,9064,9691.3%-5.1%
DepreciationRs m4254594671.7%9.9%
InterestRs m253816-59.1%-38.5%
Profit before taxRs m5,1294,8794,8890.2%-4.7%
TaxRs m1,3341,3111,282-2.2%-3.9%
Profit after taxRs m3,7953,5683,6071.1%-4.9%
Gross profit margin%39.033.935.7
Effective tax rate%26.026.926.2
Net profit margin%27.523.925.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 3.5% on a year-on-year (YoY) basis. The expenses were up by 9.0% YoY during the same period.
  • The company's operating profit declined by 5.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 35.7% in 3QFY20 as against 39.0% in 3QFY19.
  • Depreciation charges increased by 9.9% and finance costs declined by 38.5% YoY, respectively.
  • Other income increased by 16.6% YoY during the quarter.
  • Net profit for the quarter declined by 4.9% YoY. Net profit margins during the quarter declined from 27.5% in 3QFY19 to 25.2% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 3.8% on a quarter-on-quarter (QoQ) basis. The expenses were down by 6.4% QoQ during the same period.
  • The company's operating profit increased by 1.3% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 35.7% in 3QFY20 as against 33.9% in 2QFY19.
  • Net profit for the quarter increased by 1.1% QoQ, while net profit margins increased from 23.9% in 2QFY19 to 25.2% in 3QFY20.

To see how DIVIS LABORATORIES has performed over the last eight quarters,please visit here.

Get Details: First Stock to Potentially Accumulate Rs 7 Crore Long-term Wealth

DIVIS LABORATORIES Share Price Performance

Over the last one year,DIVIS LABORATORIES share price has moved up from Rs 1,654.1 to Rs 2,049.8, registering a Gain of Rs 395.7 or around 23.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,040.5 (up 0.7%). Over the last one year it has moved up from 13,863.1 to 14,040.5, a gain of 177 points (up 1.3%).

Overall, the S&P BSE SENSEX is up 12.4% over the year.

Current Valuations

At the current price of Rs 2,049.8, the price to earnings (P/E) ratio of DIVIS LABORATORIES stands at 42.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.8 times.

Equitymaster requests your view! Post a comment on "DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9%". Click here!

  

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Feb 25, 2021 03:36 PM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS